Franklin M Berger's Net Worth
Estimate Recalculated Nov 7, 2024 04:34PM EST
Who is Franklin M Berger
Franklin M Berger does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Rain Therapeutics Inc., SEATTLE GENETICS INC /WA, IMMUNE DESIGN CORP., Kezar Life Sciences, Inc., Atea Pharmaceuticals, Inc., BIOTIME INC, ESSA Pharma Inc., Tocagen Inc, Atreca, Inc., PROTEOSTASIS THERAPEUTICS, INC., EMISPHERE TECHNOLOGIES INC, FIVE PRIME THERAPEUTICS, INC., VAXGEN INC, and Asterias Biotherapeutics, Inc..
SEC CIK
Franklin M Berger's CIK is 0001273885
Past Insider Trading and Trends
2005 was Franklin M Berger's most active year for acquiring shares with 27 total transactions. Franklin M Berger's most active month to acquire stocks was the month of November. 2021 was Franklin M Berger's most active year for disposing of shares, totalling 11 transactions. Franklin M Berger's most active month to dispose stocks was the month of November. 2021 saw Franklin M Berger paying a total of $3,882,309.24 for 1,020,039 shares, this is the most they've acquired in one year. In 2019 Franklin M Berger cashed out on 265,295 shares for a total of $756,102.80, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
